Flu vaccine effectiveness in those hospitalized in a large diverse health system
Flu vaccine effectiveness in those hospitalized in a large diverse health system
批准号:
9324709
负责人:
RICHARD K ZIMMERMAN
金额:
$64.98万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-08-01 至 2020-07-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The elderly suffer the majority of influenza hospitalizations and deaths and are a priority for determining influenza vaccine effectiveness (VE). The Univ. of Pittsburgh and UPMC Health System (UPMC) are located in Allegheny County (AC), in which influenza is reportable & which has one of the 5 oldest populations in the U.S. We propose a test-negative case-control study of influenza VE in 2 UPMC hospitals to determine VE against hospitalizations of adults. UPMC has been on the US News honor roll for over a decade, including "most wired" and has a strong research tradition. The influenza season will be determined from syndromic surveillance from multiple hospital EDs, the Health Dept. (ACHD), & from lab data from >14,000 respiratory viral panels (RVP) done annually at UPMC. Theradoc informatics will identify adult inpatients who have had an RVP conducted. Enrollees' survey data will be directly entered into NIH's REDCap. Frailty can be assessed by survey and/or electronic medical record (EMR) data (e.g., Charleson Co-morbidity Index) to assess confounders and effect modifiers. Our Data Center manages REDCap data, EMR data from hospitalizations, & immunization data for uploading to CDC. Population-based incidence of influenza hospitalizations will be determined from ACHD and UPMC St. Margaret hospitalization data and by agent-based modeling at the Pittsburgh Supercomputing Center. Our team is a strong candidate for this project because: 1) UPMC is the dominant regional health system with a strong bond rating; 2) infection control personnel recommend RVPs to establish diagnoses, and our team's leadership responsibilities at the hospitals can further influence the use of RVPs; 3) we have published data showing excellent concordance between UPMC's GenMark RVP and the CDC's PCR for detecting influenza; 4) research shows better protection in the elderly from high-dose influenza (HD) vaccine; UPMC has recommended and promoted HD vaccine in large quantities, although regular vaccine is available, allowing for vaccine type comparisons; 5) UPMC's EMR links inpatient and outpatient vaccination records, and interfaces with the state immunization registry; 6) it includes diverse, well-published investigators who have worked together previously.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
RFA-IP-22-004, Evaluating respiratory virus vaccine effectiveness in a large, diverse healthcare system
-
批准号:10703261
-
项目类别:
-
资助金额:$190.0万
-
财政年份:2022
-
负责人:RICHARD K ZIMMERMAN
-
依托单位:
RFA-IP-22-004, Evaluating respiratory virus vaccine effectiveness in a large, diverse healthcare system
-
批准号:10619723
-
项目类别:
-
资助金额:$249.5万
-
财政年份:2022
-
负责人:RICHARD K ZIMMERMAN
-
依托单位:
Outpatient VE for seasonal flu, pandemic flu and RSV in a large, diverse network
-
批准号:10196884
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2016
-
负责人:RICHARD K ZIMMERMAN
-
依托单位:
Outpatient VE for seasonal flu, pandemic flu and RSV in a large, diverse network
-
批准号:9200002
-
项目类别:
-
资助金额:$110.0万
-
财政年份:2016
-
负责人:RICHARD K ZIMMERMAN
-
依托单位:
Flu vaccine effectiveness in those hospitalized in a large diverse health system
-
批准号:10227644
-
项目类别:
-
资助金额:$72.6万
-
财政年份:2015
-
负责人:RICHARD K ZIMMERMAN
-
依托单位:
Flu vaccine effectiveness in those hospitalized in a large diverse health system
-
批准号:10179288
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2015
-
负责人:RICHARD K ZIMMERMAN
-
依托单位:
A Vaccination SOP Toolkit in Diverse Practices Implemented & Tested with RE-AIM
-
批准号:8447839
-
项目类别:
-
资助金额:$29.99万
-
财政年份:2012
-
负责人:RICHARD K ZIMMERMAN
-
依托单位:
A Vaccination SOP Toolkit in Diverse Practices Implemented & Tested with RE-AIM
-
批准号:8994798
-
项目类别:
-
资助金额:$7.29万
-
财政年份:2012
-
负责人:RICHARD K ZIMMERMAN
-
依托单位:
A Vaccination SOP Toolkit in Diverse Practices Implemented & Tested with RE-AIM
-
批准号:8708522
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2012
-
负责人:RICHARD K ZIMMERMAN
-
依托单位:
A Vaccination SOP Toolkit in Diverse Practices Implemented & Tested with RE-AIM
-
批准号:8513166
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2012
-
负责人:RICHARD K ZIMMERMAN
-
依托单位:
Core_plus Option_A_C_Influenza Surveillance and Vaccine Effectiveness in a Large
-
批准号:8291877
-
项目类别:
-
资助金额:$108.5万
-
财政年份:2011
-
负责人:RICHARD K ZIMMERMAN
-
依托单位:
Core_plus Option_A_C_Influenza Surveillance and Vaccine Effectiveness in a Large
-
批准号:8234392
-
项目类别:
-
资助金额:$107.8万
-
财政年份:2011
-
负责人:RICHARD K ZIMMERMAN
-
依托单位:
Core_plus Option_A_C_Influenza Surveillance and Vaccine Effectiveness in a Large
-
批准号:8874754
-
项目类别:
-
资助金额:$141.38万
-
财政年份:2011
-
负责人:RICHARD K ZIMMERMAN
-
依托单位:
Core_plus Option_A_C_Influenza Surveillance and Vaccine Effectiveness in a Large
-
批准号:8513800
-
项目类别:
-
资助金额:$78.5万
-
财政年份:2011
-
负责人:RICHARD K ZIMMERMAN
-
依托单位:
From Innovation to Solutions: Autodialers, Use of Early Autumn Physicals and Vac
-
批准号:8135492
-
项目类别:
-
资助金额:$26.0万
-
财政年份:2010
-
负责人:RICHARD K ZIMMERMAN
-
依托单位:
From Innovation to Solutions: Autodialers, Use of Early Autumn Physicals and Vac
-
批准号:7799391
-
项目类别:
-
资助金额:$26.0万
-
财政年份:2010
-
负责人:RICHARD K ZIMMERMAN
-
依托单位:
From Innovation to Solutions: Autodialers, Use of Early Autumn Physicals and Vac
-
批准号:8317298
-
项目类别:
-
资助金额:$25.99万
-
财政年份:2010
-
负责人:RICHARD K ZIMMERMAN
-
依托单位:
From Innovation to Solutions: Autodialers, Use of Early Autumn Physicals and Vac
-
批准号:8275929
-
项目类别:
-
资助金额:$2.13万
-
财政年份:2010
-
负责人:RICHARD K ZIMMERMAN
-
依托单位:
Office Barries & Facilitators to Overcoming Disparities in Elderly Vaccinations
-
批准号:7122051
-
项目类别:
-
资助金额:$25.0万
-
财政年份:2005
-
负责人:RICHARD K ZIMMERMAN
-
依托单位:
Office Barries & Facilitators to Overcoming Disparities in Elderly Vaccinations
-
批准号:7087590
-
项目类别:
-
资助金额:$25.0万
-
财政年份:2005
-
负责人:RICHARD K ZIMMERMAN
-
依托单位:
国内基金
海外基金
新生期接种乙肝疫苗(hepatitis B vaccine,HBV)影响小鼠情绪相关行为及其机制研究
-
批准号:31600836
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2016
-
负责人:杨俊华
-
依托单位:
Endoglin基因修饰肿瘤/DC杂交细胞诱生靶向特异性抗人肺癌CTL疫苗的研究
-
批准号:30760248
-
项目类别:地区科学基金项目
-
资助金额:16.0万元
-
批准年份:2007
-
负责人:周源
-
依托单位:
胰腺癌MUC4抗原多表位嵌合DNA疫苗的设计和免疫研究
-
批准号:30500492
-
项目类别:青年科学基金项目
-
资助金额:25.0万元
-
批准年份:2005
-
负责人:高文涛
-
依托单位: